Paloma Partners Management CO Abb Vie Inc. Transaction History

Paloma Partners Management CO

$3.08 Billion
Q3 2024

A detailed history of Paloma Partners Management CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Paloma Partners Management CO holds 2,895 shares of ABBV stock, worth $521,100. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,895

Previous 14,702 80.31%

Holding current value

$521,100

Previous $2.52 Million 77.35%

% of portfolio

0.02%

Previous 0.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $1.93 Million - $2.35 Million	-11,807 Reduced 80.31%	2,895 $571,000
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $2.2 Million - $2.57 Million	14,243 Added 3103.05%	14,702 $2.52 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $338,658 - $385,869	-2,119 Reduced 82.2%	459 $83,000
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $354,732 - $399,512	2,578 New	2,578 $399,000
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $96,467 - $120,047	728 Added 495.24%	875 $117,000
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $21,257 - $24,481	147 New	147 $23,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $26,842 - $30,786	200 New	200 $27,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $2.67 Million - $3.38 Million	24,889 Added 489.56%	29,973 $4.06 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $218,864 - $248,444	-2,057 Reduced 28.81%	5,084 $548,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $1.49 Million - $1.66 Million	-14,130 Reduced 66.43%	7,141 $804,000
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $1.98 Million - $2.18 Million	19,341 Added 1002.12%	21,271 $2.3 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $1 Million - $1.35 Million	-12,431 Reduced 86.56%	1,930 $207,000
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $1.11 Million - $1.3 Million	12,864 Added 859.32%	14,361 $1.26 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $1.06 Million - $1.42 Million	-14,447 Reduced 90.61%	1,497 $147,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $389,580 - $590,651	6,040 Added 60.99%	15,944 $1.21 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $349,830 - $437,712	4,850 Added 95.96%	9,904 $877,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $10.4 Million - $12.5 Million	-165,203 Reduced 97.03%	5,054 $383,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $4.8 Million - $6.14 Million	73,066 Added 75.18%	170,257 $12.4 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $7.5 Million - $8.82 Million	97,191 New	97,191 $7.83 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $14.2 Million - $17.5 Million	-182,555 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $8.7 Million - $9.67 Million	-97,803 Reduced 34.89%	182,555 $17.3 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $21.6 Million - $25.5 Million	240,141 Added 597.11%	280,358 $26 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $3.7 Million - $4.96 Million	40,217 New	40,217 $3.81 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account

Paloma Partners Management CO Abb Vie Inc. Transaction History